Sugar beads could be new weapon against obesity
NCT ID NCT07008456
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether taking special dextrose (sugar) beads twice a day can help obese adults lose weight and improve conditions like high blood pressure and cholesterol. About 102 participants will receive either the active beads or a placebo for 24 weeks. The goal is to see if this simple approach can safely reduce body weight.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dextrose beads (a sugar-based formula) taken twice daily
What this could lead to
If it works, this could offer a new, non-surgical option for weight loss in people with obesity-related health problems.
What could go wrong
This is an early phase 2 trial with only 102 participants, so results may not apply to everyone. The treatment involves taking sugar beads, which might not lead to significant weight loss or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESE PATIENTS (BMI ≥ 30 KG/M²) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
LTD "Acad. G. Chapidze Emergency Cardiology Center"
RECRUITINGTbilisi, K'alak'i T'bilisi, 0159, Georgia
Contact Phone: •••-•••-••••
-
LTD "Diacor"
RECRUITINGTbilisi, K'alak'i T'bilisi, 0159, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LTD "Israeli-Georgian Medical Research Clinic Healthycore"
RECRUITINGTbilisi, K'alak'i T'bilisi, 0112, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LTD "New Hospitals"
RECRUITINGTbilisi, K'alak'i T'bilisi, 0114, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LTD The First Medical Center
RECRUITINGTbilisi, K'alak'i T'bilisi, 0180, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NNLE "Jo Ann University Hospital"
RECRUITINGTbilisi, K'alak'i T'bilisi, 0159, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••